Boundless Bio
Boundless Bio is a pioneer in understanding and treating the most intractable cancers. They have charted a new spatial map of the cancer genome within cancer cells and are harnessing their scientific founders' discoveries about "extrachromosomal DNA," or ecDNA, to drive a revolution in cancer therapeutics.
4
Funding Rounds
$249.5m
Money raised
Overview
Boundless Bio is a pioneer in understanding and treating the most intractable cancers. They have charted a new spatial map of the cancer genome within cancer cells and are harnessing their scientific founders' discoveries about "extrachromosomal DNA," or ecDNA, to drive a revolution in cancer therapeutics.
Funding
Funding series
Funding Series Analysis
The company Boundless Bio has raised a total of $151m in funding over 4 rounds.
Key Insights:
- Boundless Bio, Inc. funding round, May 2021: $105m
- Boundless Bio Series A round, September 2019: $46m
- Boundless Bio funding round, September 2019: $46m
- Boundless Bio, Inc. funding round, March 2020: $52.5m
Boundless Bio, Inc. funding round, May 2021
$105m
Boundless Bio Series A round, September 2019
$46m
Boundless Bio funding round, September 2019
$46m
Boundless Bio, Inc. funding round, March 2020
$52.5m
Industries
Boundless Bio is active in the following industries: